Waiving IP Protections to Address COVID-19: The WTO Proposals and Ensuring Equitable Access to the Vaccines

  • Registration Closed

Last year India and South Africa proposed to the World Trade Organization’s Council for Trade-Related Aspects of Intellectual Property Rights to “a waiver from the implementation, application and enforcement” of “intellectual property rights such as patents, industrial designs, copyright and protection of undisclosed information” under the TRIPS agreement related “to prevention, containment or treatment” of COVID-19. The proposal sparked a global debate about whether the waiver is an effective means to address the vaccine shortage or instead inaccurately portrays IP as a barrier to rapid innovation, R&D collaboration, and ample manufacturing of COVID-19 technologies.

The U.S. initially opposed the proposal, but in 2021 U.S. Trade Representative KATHERINE TAI announced U.S. support for “waiving intellectual property protections for COVID-19 vaccines.” In May, several countries and delegations including India and South Africa circulated a revised proposal that would apply to “health products and technologies including diagnostics, therapeutics, vaccines, medical devices, personal protective equipment, their materials or components, and their methods and means of manufacture for the prevention, treatment or containment of COVID-19.” The revision also proposes that the waiver remain in effect for three years after adoption unless the General Council determines that “exceptional circumstances” justify extending the waiver.

Then, in June, the European Union sent communications to the WTO General Council and to the WTO TRIPS Council regarding increasing the global supply of COVID-19 vaccines , which were intended to provide an alternative to the waiver proposal.  The EU says waiving IP protections would not increase the supply of or equitable access to vaccines. It instead recommends that the WTO agree on a global initiative to minimize export restrictions, encourage voluntary license agreements between vaccine developers and manufacturers in developing countries, and clarify existing provisions in the TRIPS agreement that already permit limited compulsory licenses.

The TRIPS Council will engage in text-based negotiations about the proposed waiver over the coming months. This webinar will share information about the status of the various proposals, the logistics of negotiations at the WTO, and the roles of various U.S. governmental and international agencies. Our esteemed panel will discuss questions such as whether a waiver would actually increase access to vaccines and other technologies, the impact of a waiver on innovation, impediments to ensuring broader vaccine access, and the effectiveness of ongoing voluntary efforts to distribute the vaccine and other important technologies more widely.

Tanuja Garde

Corporate Vice President, Intellectual Property & Licensing

Raytheon Technologies

TanujaGarde is Raytheon Technologies’ CorporateVice President, Intellectual Property & Licensing and has held thisposition since April 2020. Prior to this position, she held IP leadership rolesin other large companies. She also served in the US Government as the DeputyAssistant USTR for IP and Innovation, where she was the lead negotiator inseveral bilateral and multilateral IP and trade negotiations. Prior to her workin the government, Tanuja worked at large international law firms and alsotaught and conducted research in international and comparative patent law atthe University of London's Queen Mary IP Research Institute, where she held aHerschel Smith Research Fellowship, as well as at the Max Planck Institute forInnovation and Competition, where she was the head of the US Department. Tanujais a graduate of Duke University (with Distinction in Chemistry) and WashingtonUniversity School of Law.

David Kappos

Partner

Cravath, Swaine & Moore LLP

David J. Kappos is widely recognized as one of the world’s foremost leaders in the field of intellectual property, including intellectual property management and strategy, the development of global intellectual property norms, laws and practices as well as commercialization and enforcement of innovation‑based assets. Mr. Kappos supports the Firm’s clients with a wide range of their most complex intellectual property issues, including those pertaining to blockchain and financial technology (FinTech) as well as data security and privacy.

James Pooley

Trade Secret Expert & Attorney

James Pooley, PLC

James Pooley founded his own firm in Silicon Valley in 2015, after serving for five years as the Deputy Director General of the World Intellectual Property Organization. His legal treatise, “Trade Secrets,” is updated semi-annually. He acts as co-counsel in trade secret and patent litigation, and acts as consultant regarding trade secret and cybersecurity risks. Earlier he was an IP litigator and partner at Morrison & Foerster and Milbank, among other firms. He is also the author of Secrets: Managing Information Assets in the Age of Cyberespionage. 

Tony Rollins

European Patent Attorney

Rollins IP Strategies Ltd.

Tony Rollins of Rollins IP Strategies Ltd. is an experienced IP practitioner who is based in the United Kingdom. At the Wellcome Foundation, he handled a diverse range of work in the pharmaceutical, diagnostic, animal health, environmental health and hygiene areas. He later served as Vice President of Intellectual Property of Amersham plc, headed up the European Patents group of MSD, and also led MSD’s Japanese patent department. Tony is the current chair of the International Liaison Committee and the former President of the Chartered Institute of Patent Attorneys. He is President of the Global Network of National IP Practitioner Associations.

Key:

Complete
Failed
Available
Locked
Waiving IP Protections to Address COVID-19: The WTO Proposals and Ensuring Equitable Access to the Vaccines
06/30/2021 at 12:00 PM (EDT)   |  60 minutes
06/30/2021 at 12:00 PM (EDT)   |  60 minutes
Evaluation Survey
13 Questions
CLE Credit
4 Questions
4 Questions CLE credit will be available for registered attendees only. If you would like CLE credit for this webinar, please complete the following questions. IPO will apply for CLE for all live programs in the majority of the states that require CLE. IPO will not be applying for CLE in the states of Florida, Ohio, South Carolina, West Virginia, or Texas (attorneys in TX may submit up to 5 hours of self-study credit). Once IPO has received approval from the state(s) CLE boards , certificate(s) of attendance will be available for download from your dashboard.
CA Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available California has approved this course for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" to claim your records.
CT Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available This course was approved in Indiana, a CT approved jurisdiction, for 1 hour of CLE credit. Only registered attendees that viewed the program are eligible to claim credit. To claim your credit, select “claim credits” and then “view/print your certificate” for your records.
General Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available This is a general certificate of attendance for this webinar, for those who applied for CLE credit for a state with no minimum continuing legal education (MCLE) requirement for attorneys or students seeking a record of attendance. This course has been approved for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate for your records.
ID Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Idaho has approved this course for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
IL Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Illinois has approved this course for 1 hour of CLE credit. Only registered attendees that viewed the course are eligible to claim credit. To claim credit, select "Claim Credit" then "View/Print Certificate" for your records.
IN Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Indiana has approved this course for 1 hour of CLE credit. Only registered attendees that approved this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
NJ Certificate of Attendance
Up to 1.20 CLE credits available  |  Certificate available
Up to 1.20 CLE credits available  |  Certificate available New Jersey has approved this webinar for 1.2 hours of CLE credit. Only registered attendees that viewed the program are eligible to claim credit. To claim your credit, select "Claim Credits" and then "View/Print your certificate" for your records.
NY Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available This course was approved in Indiana, a NY approved jurisdiction, for 1 hour of CLE credit. Only registered attendees that viewed the program are eligible to claim credit. To claim your credit, select “claim credits” and then “view/print your certificate” for your records.
PA Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Pennsylvania has approved this course for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
VA Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Virginia has approved this course for 1 hour of CLE credit. Only registered attendees that viewed the course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
VT Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Vermont has approved this course for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to receive credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
Waiving IP Protections to Address COVID-19: The WTO Proposals and Ensuring Equitable Access to the Vaccines (RECORDING)
Open to view video.
Open to view video.